Oppenheimer Starts Neurocrine Bio. (NBIX) at Perform

November 21, 2016 4:15 PM EST
Get Alerts NBIX Hot Sheet
Price: $43.23 +0.02%

Rating Summary:
    15 Buy, 2 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 11 | Down: 31 | New: 42
Trade NBIX Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Oppenheimer initiates coverage on Neurocrine Bio. (NASDAQ: NBIX) with a Perform rating and a price target of $55.00.

Analyst Jay Olson commented, "We initiate coverage of Neurocrine Biosciences (NBIX) with a Perform rating and a $55 price target. NBIX develops drugs that modulate the CNS and endocrine systems, thus targeting movement disorders and women’s health. We appreciate the company’s impressive pipeline progress in two distinct therapeutic areas but remain agnostic given the stock's current price, which is near our price target."

For an analyst ratings summary and ratings history on Neurocrine Bio. click here. For more ratings news on Neurocrine Bio. click here.

Shares of Neurocrine Bio. closed at $51.01 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, New Coverage

Add Your Comment